BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12926088)

  • 21. Proteomics of breast cancer: enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors.
    Zhang DH; Tai LK; Wong LL; Sethi SK; Koay ES
    Proteomics; 2005 May; 5(7):1797-805. PubMed ID: 15825149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kit expression in male germ cell tumors.
    Nikolaou M; Valavanis C; Aravantinos G; Fountzilas G; Tamvakis N; Lekka I; Arapantoni-Dadioti P; Zizi A; Ghiconti I; Economopoulos T; Pectasides D
    Anticancer Res; 2007; 27(3B):1685-8. PubMed ID: 17595797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
    Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
    Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases.
    Malagón HD; Valdez AM; Moran CA; Suster S
    Am J Surg Pathol; 2007 Sep; 31(9):1356-62. PubMed ID: 17721191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen receptor-beta expression in human testicular germ cell tumors.
    Pais V; Leav I; Lau KM; Jiang Z; Ho SM
    Clin Cancer Res; 2003 Oct; 9(12):4475-82. PubMed ID: 14555521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical detection of p63 in testicular germ cell neoplasia.
    Emanuel PO; Unger PD; Burstein DE
    Ann Diagn Pathol; 2006 Oct; 10(5):269-73. PubMed ID: 16979518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary germ cell tumors of the mediastinum: I. Analysis of 322 cases with special emphasis on teratomatous lesions and a proposal for histopathologic classification and clinical staging.
    Moran CA; Suster S
    Cancer; 1997 Aug; 80(4):681-90. PubMed ID: 9264351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic and predictive value of immunohistochemically detected HER-2/neu overexpression in 361 patients with ovarian cancer: a multicenter study.
    Riener EK; Arnold N; Kommoss F; Lauinger S; Pfisterer J
    Gynecol Oncol; 2004 Oct; 95(1):89-94. PubMed ID: 15385115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of Fhit expression in testicular germ cell tumors and intratubular germ cell neoplasia.
    Eyzaguirre E; Gatalica Z
    Mod Pathol; 2002 Oct; 15(10):1068-72. PubMed ID: 12379753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spontaneous regression of testicular germ cell tumors: an analysis of 42 cases.
    Balzer BL; Ulbright TM
    Am J Surg Pathol; 2006 Jul; 30(7):858-65. PubMed ID: 16819328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha-fetoprotein in germ cell tumors. An immunohistochemical study.
    Chaudhary RK; Kher A; Bobhate SK; Grover S
    Indian J Pathol Microbiol; 1989 Jul; 32(3):167-73. PubMed ID: 2476392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of CD117 in human testicular germ cell tumors and its diagnostic value for seminoma and nonseminoma].
    Liu DL; Lu YP; Shi HY; Zhu SX; Lü JW; Li WF; Rong X
    Zhonghua Nan Ke Xue; 2008 Jan; 14(1):38-41. PubMed ID: 18297810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of HER-2/neu overexpression on chemoresistance and prognosis in ovarian carcinoma.
    Sasaki N; Kudoh K; Kita T; Tsuda H; Furuya K; Kikuchi Y
    J Obstet Gynaecol Res; 2007 Feb; 33(1):17-23. PubMed ID: 17212661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer.
    Osman I; Scher HI; Drobnjak M; Verbel D; Morris M; Agus D; Ross JS; Cordon-Cardo C
    Clin Cancer Res; 2001 Sep; 7(9):2643-7. PubMed ID: 11555574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ploidy of primary germ cell tumors of the testis. Pathogenetic and clinical relevance.
    Oosterhuis JW; Castedo SM; de Jong B; Cornelisse CJ; Dam A; Sleijfer DT; Schraffordt Koops H
    Lab Invest; 1989 Jan; 60(1):14-21. PubMed ID: 2536126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Importance of determination of various histologic components in testicular germ cell tumors].
    Kruslin B; Turcić M; Cupić H; Novosel I; Reljić A; Ruzić B; Belicza M
    Lijec Vjesn; 2003; 125(9-10):242-5. PubMed ID: 15038213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA-G in testicular germ cell tumors.
    Karagöz B; Haholu A; Ozgün A; Bilgi O; Tunçel T; Emirzeoğlu L; Celik S; Demirel D
    Oncol Res Treat; 2014; 37(5):245-8. PubMed ID: 24853783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of HER-2/neu protein overexpression with other prognostic and predictive factors in invasive ductal breast cancer.
    Ivkovic-Kapicl T; Knezevic-Usaj S; Djilas-Ivanovic D; Panjkovic M
    In Vivo; 2007; 21(4):673-8. PubMed ID: 17708365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical outcome of adult testicular tumor. II. Study on patients with positive human chorionic gonadotropin].
    Sakuramoto T; Kihara K; Kawai T
    Hinyokika Kiyo; 1984 May; 30(5):639-49. PubMed ID: 6089533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.